Solving the nuclear isotopes shortage

Accelerator facilities suggested for hospitals

At the end of January, the of Concerned Scientists issued a call to improve supplies of nuclear isotopes, which is used in medical imaging. In the face of no firm plans to solve these problems, Tom Ruth, of TRIUMF, Vancouver, Canada, has proposed both short and long-term visions for the future in an Essay in the science journal Nature.

Four-fifths of the most widely-used radionuclide comes from just two nuclear reactor facilities: one in the Netherlands; one in Canada. Due to the short half-life of the isotope, stockpiling for more than a couple of days is impossible. Unexpected closures of both of these aging facilities over the past 18 months caused panic and the cancellation of medical procedures. In addition, both facilities make use of highly enriched uranium, seen by some as a terrorism risk.
Ruth’s solution is to replace reactor-made isotopes with ones made from an accelerator. This is cheaper and safer, as it does not involve highly enriched uranium, but requires the Canadian government to take steps to retain its role as a world leader in nuclear medicine. His vision for the future involves equipping more hospitals with their own accelerator facilities, so that different isotopes can be used to produce clearer, better medical images.
Details: www.nature.com/nature. Essay publication date: 29/1/09.
Tom Ruth: truth@triumf.ca

01.03.2009

Related articles

Photo

Article • Institutional setup guide at SNMMI 2024

How to establish a hospital theranostics treatment centre

The nuclear medicine global market is projected to see a significant increase in the coming years, with the lion's share being attributed to radiotherapeutics. So, how to set up a dedicated…

Photo

News • Nuclear medicine

Lung fibrosis: radiopharmaceutical improves diagnosis and monitoring

Nuclear medicine specialists have successfully used the radiopharmaceutical Ga-68-Trivehexin from Trimt to accurately diagnose patients with pulmonary fibrosis and concurrent lung cancer.

Photo

News • Triple-negative breast cancer

Novel radiotracer identifies TNBC biomarker

A new PET tracer has the potential to play a critical role in the diagnosis, treatment, and monitoring of aggressive triple-negative breast cancer (TNBC), improving clinical outcomes for patients.

Related products

Subscribe to Newsletter